Insight Molecular Diagnostics (IMDX) FCF Margin Growth (3y) (2023 - 2026)
Insight Molecular Diagnostics (IMDX) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 221.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -682.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,227.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -891.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 175.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 819.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 896.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 327.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 23.00 |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -272,817.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -272,817.00 |
| Mar 31, 2026 | -2.30 Mn |
| Dec 31, 2025 | 61,418.00 |
| Sep 30, 2025 | -89,308.00 |
| Jun 30, 2025 | -58,358.00 |
| Mar 31, 2025 | 113,380.00 |
| Dec 31, 2024 | -16,647.00 |
| Sep 30, 2024 | -372,815.00 |
| Jun 30, 2024 | -550,474.00 |
| Mar 31, 2024 | -123,986.00 |
| Dec 31, 2023 | -23,852.00 |
| Sep 30, 2023 | 42,967.00 |
| Jun 30, 2023 | 373,559.00 |
| Mar 31, 2023 | 4.04 Mn |